Obesity is a complex, chronic disease and global public health challenge. Characterized by
excessive fat accumulation in the body, obesity sharply increases the risk of several …

Obesity is a serious and growing worldwide health challenge. Healthy lifestyle choices are
the foundation of obesity treatment. However, weight loss can lead to physiological …

Objective: To formulate clinical practice guidelines for the pharmacological management of
obesity. Participants: An Endocrine Society-appointed Task Force of experts, a …

Obesity is among the leading causes of morbidity and mortality worldwide and its
prevalence continues to increase globally. Because obesity is a chronic, complex, and …

As obesity rates increase, so too do the risks of type 2 diabetes, cardiovascular disease, and
numerous other detrimental conditions. The prevalence of obesity in US adults more than …

New therapeutic and preventative strategies are needed to address the growing obesity
epidemic. In animal models, brown adipose tissue activation and the associated heat …

Obesity, a primary influence on health condition, causes numerous comorbidities and
complications and, therefore, pharmacotherapy is considered a strategy for its treatment …

Prader–Willi syndrome (PWS) is a complex multisystem disorder due to the absent
expression of the paternally active genes in the PWS critical region on chromosome 15 …

Pharmacotherapy directed toward reducing body weight may provide benefits for both
curbing obesity and lowering the risk of obesity‐associated comorbidities; however, many …

Childhood obesity is characterized by an increased risk of several metabolic derangements
including insulin resistance (IR). The strongest recommendations to prevent obesity and …